2022
DOI: 10.1016/j.ajoc.2022.101606
|View full text |Cite
|
Sign up to set email alerts
|

Rapid symptomatic and structural improvement of a retinal astrocytic hamartoma in response to anti-VEGF therapy: A case report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 27 publications
0
3
0
Order By: Relevance
“…If TSC is suspected, the primary concern must be initiating the systemic workup with neuroimaging (choice B), as the central nervous system manifestations of TSC can be life threatening. Secondarily, treatment for the ophthalmic complications of the disease can be considered, such as with anti–vascular endothelial growth factor (anti-VEGF) medications for secondary exudation (choice A) . Retinal hamartomas are not typically associated with a hypercoagulable state or cardiac concerns (choices C and D).…”
Section: Discussionmentioning
confidence: 99%
“…If TSC is suspected, the primary concern must be initiating the systemic workup with neuroimaging (choice B), as the central nervous system manifestations of TSC can be life threatening. Secondarily, treatment for the ophthalmic complications of the disease can be considered, such as with anti–vascular endothelial growth factor (anti-VEGF) medications for secondary exudation (choice A) . Retinal hamartomas are not typically associated with a hypercoagulable state or cardiac concerns (choices C and D).…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies have shown that astrocytic hamartomas, especially in patients with TSC, may be intrinsically associated with VEGF signaling for their structure and exudative properties independent of their ability to promote neovascularization. 8 , 25 , 26 Some case reports exhibit clinical improvement in response to anti -VEGF therapy without requiring any evidence of pre-retinal or choroidal neovascularization. 26 , 27 , 28 As vein occlusions can cause VEGF overproduction, avoiding to do proper management may cause tumor growth and secondary mentioned complications.…”
Section: Discussionmentioning
confidence: 99%
“… 8 , 25 , 26 Some case reports exhibit clinical improvement in response to anti -VEGF therapy without requiring any evidence of pre-retinal or choroidal neovascularization. 26 , 27 , 28 As vein occlusions can cause VEGF overproduction, avoiding to do proper management may cause tumor growth and secondary mentioned complications. 29 …”
Section: Discussionmentioning
confidence: 99%